Back to search
FDAFDA · Food and drugs·Recall number D-1483-2014

Aspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. By: McKesson Packaging Services a business unit of McKesson Corporation, concord, NC

Published August 6, 2014 · Recall initiated: June 19, 2014

Summary

FDA records drug Class III recall D-1483-2014, published August 6, 2014 and initiated June 19, 2014. Recalling firm: Mckesson Packaging Services; Status: Terminated; Reported quantity: 1,511,250 tablets; Lot: Lot 0093943. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification; at the 12 month time interval.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Packaging Services
Distributor
Nationwide
Lot
Lot 0093943
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. By: McKesson Packaging Services a business unit of McKesson Corporation, concord, NC recalled?

Yes. FDA published recall D-1483-2014 on August 6, 2014. Reported hazard: Failed Dissolution Specification; at the 12 month time interval.

What should I do if I have this product?

Voluntary: Firm initiated · Letter